FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Positive data from oral therapy designed to improve muscle function and body composition
New insights into genome ejection from AAV vectors
New drug for diabetes and obesity shows promising results
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
New nanoparticles offer safer, more effective drug delivery
Two key proteins perform powerful functions on a major secretory pathway
RyboDyn joins Lilly Gateway Labs to advance next-gen immunotherapies
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them
FDA Fast Track Designation for gel to treat calciphylaxis ulcers